While Tang et al. (2025) emphasized inflammatory and genetic signatures through multi‐omics profiling, our transcriptomic analysis revealed distinct molecular pathways (SST/CUX2 vs. CRH signaling) that may capture orthogonal aspects of MDD heterogeneity. This evidence concerns the gene CRH and major depressive disorder.